318 related articles for article (PubMed ID: 6294790)
21. GR-20263: a new aminothiazolyl cephalosporin with high activity against Pseudomonas and Enterobacteriaceae.
Verbist L; Verhaegen J
Antimicrob Agents Chemother; 1980 May; 17(5):807-12. PubMed ID: 6994640
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of cefotaxime, ceftizoxime, cefmenoxime, and latamoxef in comparison with other beta-lactam antibiotics against recent clinical isolates of Haemophilus influenzae and Haemophilus parainfluenzae.
Kawakami Y; Okimura Y; Horiuchi N; Kanai M
Microbiol Immunol; 1982; 26(7):617-21. PubMed ID: 6290854
[No Abstract] [Full Text] [Related]
23. Beta-lactamase-positive strains of Haemophilus influenzae: susceptibility to and inactivation of beta-lactam antibiotics.
Anderson EL; Robinson PA; Tu KK; Adams CR
South Med J; 1985 Jun; 78(6):643-6. PubMed ID: 3873708
[TBL] [Abstract][Full Text] [Related]
24. [In vitro bacteriostatic activity of cefmenoxime (SCE 1365), cefotaxime and moxalactam].
Husson MO; Bryskier A; Izard D; Leclerc H
Pathol Biol (Paris); 1983 May; 31(5):347-50. PubMed ID: 6312395
[TBL] [Abstract][Full Text] [Related]
25. [Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins].
Baumgärtner M; Dickgiesser N; Müller S; Wundt W
Arzneimittelforschung; 1981; 31(10):1677-81. PubMed ID: 6274361
[TBL] [Abstract][Full Text] [Related]
26. In vitro antibacterial activity of a new 1-oxa cephalosporin compound.
Downs JT; Andriole VT
Yale J Biol Med; 1980; 53(2):149-59. PubMed ID: 6446810
[TBL] [Abstract][Full Text] [Related]
27. Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative.
Eickhoff TC; Ehret J
Antimicrob Agents Chemother; 1981 Mar; 19(3):435-42. PubMed ID: 6264845
[TBL] [Abstract][Full Text] [Related]
28. The activity of cefbuperazone, a 7 alpha-methoxy 7 beta acyl ureido cephalosporin.
Neu HC; Chin NX; Labthavikul P
Chemioterapia; 1985 Dec; 4(6):415-23. PubMed ID: 3879464
[TBL] [Abstract][Full Text] [Related]
29. Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli.
Lang SD; Edwards DJ; Durack DT
Antimicrob Agents Chemother; 1980 Mar; 17(3):488-93. PubMed ID: 6252831
[TBL] [Abstract][Full Text] [Related]
30. Antibacterial activity of the cephamycin cefotetan: an in-vitro comparison with other beta-lactam antibiotics.
Clarke AM; Zemcov SJ
J Antimicrob Chemother; 1983 Jan; 11 Suppl():67-72. PubMed ID: 6404881
[TBL] [Abstract][Full Text] [Related]
31. [In vitro activity of combinations of cefotaxime and moxalactam with aminoglycosides on beta-lactamase-producing Enterobacteriaceae].
Sirot J; Sirot D; Garnier R; Joly B; Cluzel R
Pathol Biol (Paris); 1983 Jun; 31(6):480-2. PubMed ID: 6308542
[TBL] [Abstract][Full Text] [Related]
32. In-vitro activity of the novel oxa-beta-lactam antibiotic moxalactam (LY 127935) against dense populations of selected Gram-negative bacilli.
Greenwood D; Eley A; Pearson N; O'Grady F
J Antimicrob Chemother; 1981 Apr; 7(4):353-62. PubMed ID: 6265424
[TBL] [Abstract][Full Text] [Related]
33. [Antibacterial activity of cefmenoxime against clinical isolates. Comparative study].
Takahashi C; Miyazawa K
Jpn J Antibiot; 1985 Jan; 38(1):27-30. PubMed ID: 3886949
[TBL] [Abstract][Full Text] [Related]
34. Cefotaxime: a review of in vitro antimicrobial properties and spectrum of activity.
Jones RN; Thornsberry C
Rev Infect Dis; 1982; 4 Suppl():S300-15. PubMed ID: 6294779
[TBL] [Abstract][Full Text] [Related]
35. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
George WL; Lewis RP; Meyer RD
Antimicrob Agents Chemother; 1978 Mar; 13(3):484-9. PubMed ID: 122524
[TBL] [Abstract][Full Text] [Related]
36. In vitro activity and stability against novel beta-lactamases of investigational beta-lactams (cefepime, cefpirome, flomoxef, SCE2787 and piperacillin plus tazobactam) in comparison with established compounds (cefotaxime, latamoxef and piperacillin).
Bauernfeind A; Schweighart S; Eberlein E; Jungwirth R
Infection; 1991; 19 Suppl 5():S264-75. PubMed ID: 1664418
[TBL] [Abstract][Full Text] [Related]
37. Antibacterial activity of aztreonam: a synthetic monobactam. A comparative study with thirteen other antibiotics.
Paradelis AG; Stathopoulos GA; Salpigides GN; Crassaris LG
Methods Find Exp Clin Pharmacol; 1983; 5(6):375-83. PubMed ID: 6684718
[TBL] [Abstract][Full Text] [Related]
38. An in-vitro comparison of new cephalosporins with special reference to Pseudomonas aeruginosa.
van Klingeren B
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():97-105. PubMed ID: 19810171
[TBL] [Abstract][Full Text] [Related]
39. Aminoglycoside-resistant gram-negative bacilli in a community hospital: comparative in vitro activity of cefotaxime, moxalactam, cefoperazone, and piperacillin.
Magnussen CR; Sammartino MT; Ernest KD
Antimicrob Agents Chemother; 1982 Jul; 22(1):154-6. PubMed ID: 6289736
[TBL] [Abstract][Full Text] [Related]
40. Activity of moxalactam and cefotaxime alone and in combination with ampicillin or penicillin against group B streptococci.
Landesman SH; Corrado ML; Cherubin CE; Sierra MF
Antimicrob Agents Chemother; 1981 May; 19(5):794-7. PubMed ID: 6271048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
